Ruffer LLP’s 4D Pharma PLC LBPS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-195,954
Closed -$320K 104
2022
Q2
$320K Hold
195,954
0.01% 92
2022
Q1
$945K Hold
195,954
0.02% 85
2021
Q4
$1.07M Hold
195,954
0.03% 73
2021
Q3
$1.2M Hold
195,954
0.04% 58
2021
Q2
$2.09M Buy
+195,954
New +$2.27M 0.06% 56

Ruffer LLP's LBPS Position: Q3 2022 in Review

Ruffer LLP sold out of 4D Pharma PLC (LBPS) in Q3 2022, closing a stake of 195,954 shares — an estimated $320K sold.

Ruffer LLP first reported a position in LBPS in Q2 2021 and held it in 5 quarters. The position peaked at $2.09M in Q2 2021. 1 fund tracked by Wall St. Rank holds LBPS as of Q3 2022.

  • Ruffer LLP reported no remaining 4D Pharma PLC position as of Q3 2022 after selling out during the quarter.
  • Ruffer LLP sold 195,954 4D Pharma PLC shares in Q3 2022, an estimated $320K.
  • Ruffer LLP first reported a position in 4D Pharma PLC in Q2 2021 and held it in 5 quarters.
  • Ruffer LLP's 4D Pharma PLC position peaked at $2.09M in Q2 2021.
  • 1 fund tracked by Wall St. Rank held 4D Pharma PLC as of Q3 2022.

Based on Ruffer LLP's 13F filing for Q3 2022, filed 10 Nov 2022.